Mr. Speaker, in a press conference given moments ago, NACI recommended mRNA vaccines over the AstraZeneca and Johnson & Johnson vaccines, saying that, given reports of blood clotting, individuals should be able to make an informed choice on whether they should wait to take an mRNA vaccine. A representative from NACI actually said they do not know how common the incidents of blood clotting are with those two vaccines, suggesting that the incidents might be as high as one in 100,000.
Therefore, what does Health Canada advise? This is different than what we have been hearing. Does Health Canada advise taking the first vaccine offered or to wait, if one can, for an mRNA vaccine?